Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

North Africa medtech opportunities re-emerging, but risks need to be weighed

This article was originally published in Clinica

Executive Summary

Away from the BRIC markets, but also showing much potential for growth, the countries of North Africa represent a potentially lucrative, often overlooked, opportunity. The “Arab spring” events, which sparked in Tunisia in December 2010 and spread to Egypt, Morocco, Algeria and Libya in 2011, did much to close down local business prospects. But with stability now coming to the markets, global medtech manufacturers are once more eyeing the potential of this import-dominated region.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT100217

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel